[Anticoagulation and peripartum management]

Gynecol Obstet Fertil. 2015 Mar;43(3):187-90. doi: 10.1016/j.gyobfe.2015.01.008. Epub 2015 Feb 21.
[Article in French]

Abstract

Objective: To compare peripartum management of anticoagulated patients concerning locoregional analgesia, post-partum hemorrhage and thrombotic events according to planified interruption or not of antithrombotic therapy.

Patients and methods: We conducted a single tertiary care center retrospective study of all deliveries associated with antithrombotic therapy from January 2005 to September 2011.

Results: We identified 120 cases with prophylactic (71%) or curative (29%) anticoagulation. Two thrombotic events occurred. In case of curative therapy, the use of locoregional analgesia was lower (P<0.0001) and post-partum hemorrhage occurred more frequently (P=0.07) compared to prophylactic therapy. According to planified interruption or not of antithrombotic therapy, we observed a more prolonged duration of therapeutic interruption before delivery (55.6h±63.3 vs 26.4 h±11.6, P<0.0001), higher use of locoregional analgesia (83% vs 71%, P=0.02) but no difference concerning cesarean rate (35% vs 39%, P=0.8) or post-partum hemorrhage (13% vs 14%, P=0.9).

Conclusion: In case of curative anticoagulation, plannified interruption favours the use of perimedullar analgesia after 24hour delay. In case of preventive anticoagulation, plannified interruption appears unnecessary as the 12hour delay is easier to reach.

Keywords: Accouchement; Analgésie périmédullaire; Anticoagulation; Complication thromboembolique; Delivery; Hémorragie du post-partum; Locoregional analgesia; Peripartum; Post-partum hemorrhage; Péri-partum; Thromboembolic event.

MeSH terms

  • Adult
  • Analgesia / statistics & numerical data
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Cesarean Section / statistics & numerical data
  • Female
  • Humans
  • Peripartum Period*
  • Postpartum Hemorrhage / epidemiology
  • Pregnancy
  • Retrospective Studies
  • Tertiary Care Centers

Substances

  • Anticoagulants